NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/11/2019
Back to search
Official data from USPTO
KAMIYA BIOMEDICAL COMPANY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KAMIYA BIOMEDICAL COMPANY
ST13
US500000075536507Class
5
Filing
75536507
Registration
2310978
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
10/11/2019
Trademark type
Word
Nice classes
5
Filing date
08/13/1998
Registration date
01/25/2000
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/11/2019
Last transaction
10/11/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/01/1983
First use in commerce
03/01/1983
Drawing code
1
Owner type
16
Owner location
TUKWILA, WA
Examiner
JOHNSON, AISHA
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
KAMIYA BIOMEDICAL COMPANY, LLC
Kamiya, Kohji
Representatives
Colin Getty KAMIYA BIOMEDICAL COMPANY, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Clinical testing in vitro diagnostic kits comprised primarily of reagentscalibratorscontrols
Publications
History of USPTO decisions and trademark events.
28 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/11/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/11/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/11/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/06/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
09/06/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/27/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/25/2019
CFIT
CASE FILE IN TICRS
06/08/2011
CFIT
CASE FILE IN TICRS
06/03/2011
CFIT
CASE FILE IN TICRS
05/26/2011
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/20/2009
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/20/2009
PLGL
ASSIGNED TO PARALEGAL
03/12/2009
E89R
TEAS SECTION 8 & 9 RECEIVED
03/11/2009
PLGL
ASSIGNED TO PARALEGAL
09/27/2006
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/02/2006
PLGL
ASSIGNED TO PARALEGAL
03/02/2006
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
12/06/2005
ES8R
TEAS SECTION 8 RECEIVED
12/06/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2000
PUBO
PUBLISHED FOR OPPOSITION
11/02/1999
NPUB
NOTICE OF PUBLICATION
10/01/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/1999
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/1999
CNRT
NON-FINAL ACTION MAILED
04/30/1999
DOCK
ASSIGNED TO EXAMINER
04/30/1999
DOCK
ASSIGNED TO EXAMINER
04/02/1999
Continuous trademark protection
Get notified about every new filing that threatens KAMIYA BIOMEDICAL COMPANY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.